It was so difficult to get on the S&P 500 (INDEX: .SPX)'s list of top 10 performers in 2016; Jim Cramer says it will be hard to have a repeat performance in 2017.

"Some of the S&P's biggest winners from last year have run out of fuel," the " Mad Money " host said.

For example, the top performer of the S&P in 2016 was Nvidia (NASDAQ: NVDA), which more than doubled. The trajectory of the stock was steadily climbing higher until it suddenly skyrocketed in November to $117 from $68, before hitting $107 in the last days of the year.

Nvidia reminded Cramer of Intel (NASDAQ: INTC) or Qualcomm (NASDAQ: QCOM) in their heyday. Unfortunately, as the markets for PCs and cellphone chips matured, so did the stock.

And while Nvidia could head higher after it settles, Cramer said the numbers would need to come up substantially because of its sky high valuation.

Other winners of the S&P were Oneok (NYSE: OKE), Freeport-McMoRan (NYSE: FCX), Newmont Mining (NYSE: NEM), Applied Materials (NASDAQ: AMAT), Quanta Services (NYSE: PWR), Comerica (NYSE: CMA), Martin Marietta Materials (NYSE: MLM) and Halliburton.

"I think HAL's got a long way to go even after last year's 58 percent run, although I prefer competitor Schlumberger (NYSE: SLB)," Cramer said.

However, many of the stocks in the S&P were depressing for Cramer. They were stocks that were once great based on models that have either gone away or changed by events.

The worst performer of the S&P was Endo International (NASDAQ: ENDP), down 73 percent in 2016. For Cramer, this company embodied everything that used to work before 2016, ranging from its tax-inverted headquarters in Dublin, strong generic drug profile and acquisitive management.

The federal government made it much harder for companies to execute tax arbitrage, thus Endo suffered. Endo's new management is now struggling with price pressure and its $8 billion debt load.

The second worst performer was First Solar (NASDAQ: FSLR), down 51 percent last year. Cramer thinks this one was simply a case of being in the wrong industry at the wrong time.

"I think that selling ice to Eskimos might be more lucrative than selling solar panels," Cramer said.

Other losers of the S&P were TripAdvisor (NASDAQ: TRIP), Perrigo (NYSE: PRGO), Vertex Pharmaceuticals (NASDAQ: VRTX), Mallinckrodt (NYSE: MNK), Allergan (NYSE: AGN), Regeneron (NASDAQ: REGN) and Stericycle (NASDAQ: SRCL).

Ultimately, Cramer chose Halliburton, Comerica, Quanta Services, Applied Materials, Oneok and Nvidia as stocks that could have more upside in 2017. Unfortunately, the other 494 other companies don't seem to be up to snuff for a wild year ahead.

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram - Vine

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

More From CNBC

• Top News and Analysis
  

• Latest News Video
  

• Personal Finance